A new immunotherapy drug could help some cancer patients avoid surgery.
According to the results of a new study in the New England Journal of Medicine, 92% of patients who took this drug were cancer-free after two years.
Dr. Andrea Cercek, an oncologist at Memorial Sloan Kettering Cancer Center in New York, joins us to discuss.
This article was originally published on WBUR.org.
Copyright 2025 WBUR
